Yemen, Lebanon allege India’s Celon Labs’ drug ‘substandard’
The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories,.
BioNTech, a Germany-based biotechnology company, is expected to spend between 2.4 million euros and 2.6 million euros on research this year compared with.
A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal.
The pill, revumenib, has shown benefit in treating both adults and children with certain type of acute leukemia.
Progestin-only contraceptive use increases breast cancer risk similarly to combined contraceptive use.
BioNTech, a German immunotherapy company, announced a strategic pact with OncoC4, a private firm, to develop and commercialise a drug to treat solid tumours.
The WHO’s scientific advisors have called on China to release all data relating to the COVID-19 origins after a new report hinted at.
India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of.
The FDA’s advisory panel recommended full approval of Pfizer’s Covid antiviral treatment Paxlovid for high-risk adults.
The WHO slammed the Chinese authorities for not being transparent in sharing data related to COVID-19 origins and urged Beijing to conduct "investigations.